Australia markets closed

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6100-0.0021 (-0.34%)
At close: 04:00PM EDT
0.6110 +0.00 (+0.16%)
After hours: 07:19PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.09-0.1-0.4-0.31
Low estimate-0.1-0.11-0.41-0.35
High estimate-0.09-0.1-0.39-0.28
Year ago EPS-0.16-0.14-0.61-0.4
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.18-0.17-0.15-0.12
Actual EPS-0.16-0.14-0.12-0.1
Difference0.020.030.030.02
Surprise %11.10%17.60%20.00%16.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.09-0.1-0.4-0.31
7 days ago-0.09-0.1-0.41-0.45
30 days ago-0.11-0.12-0.5-0.45
60 days ago-0.13-0.14-0.58-0.56
90 days ago-0.13-0.14-0.58-0.56
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMNPRIndustrySector(s)S&P 500
Current qtr.43.80%N/AN/AN/A
Next qtr.28.60%N/AN/AN/A
Current year34.40%N/AN/AN/A
Next year22.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A